StockGuru Blog: ALR Technologies, Inc. – Medication Crucial for Transplant Patients

ALRT — ALR Technologies, Inc. Stock Guru Profile ALR Technologies Inc. (ALRT – OTCBB) ALR Technologies Supports Healthcare Industry with Cost Effective System and Generates Ongoing Revenue Stan Cruitt, CEO of ALR Technologies, when commenting on the article regarding medication and transplant patients which was included in our blog today noted, “This is a significant issue in healthcare today. While it is always important for a patient to be compliant with medications and treatments the underlying reality is that an entire organ transplant procedure can be undermined by medication non-compliance. This is what Medicare and Medicaid are beginning to understand, that the home healthcare compliance industry will rapidly growing and become an essential component of US healthcare. Health management compliance is one that is demonstrably cost efficient in terms of dollars and in terms of societal cost. There are an insufficient number of organ donors and we cannot afford as a society to allow this important, life giving surgery to be compromised by failure in medication compliance.” ALR Technologies, Inc. Press Release: ALR Technologies to Begin Marketing to Organ Transplant Programs in U.S. Stay tuned for more on this company as we look at the recurring and regenerative revenue stream provided by this system. Source: ALR Technologies, Inc. and Mercom Capital Group, LLC Stay tuned for more on this company. Wendy Prabhu, Investor Relations for ALR Technologies, Inc. Phone: (512) 828-6645 Email: alrt@mercomcapital.com Sidney Chan, CEO ALRT — ALR Technologies, Inc. 114M Reynolda Village Winston-Salem, NC 27106 Website: http://www.alrt.com Phone: (336) 722-2254 SOURCE: ALR Technologies, Inc. and New England Journal of Medicine and Managed Healthcare Executive; Sep2006, Vol. 16 Issue 9, p44-51, 4p Safe Harbor and Forward Looking Statement:Certain statements set forth in this article constitute “forward-looking statements.” Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company’s actual results and financial position to differ materially from those included within the forward-looking statements, including the Company’s ability to obtain sufficient financing to fund both its internal growth opportunities and acquisition strategy. More information about the potential risks and factors that could affect the Company’s business and financial results is included in the Company’s filings, available via the United States Securities and Exchange Commission at http://www.sec.gov/. Disclosure: Pentony Enterprises LLC was compensated from non-controlling third party $15,000.00 for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.